Successful examples of tumor immunotherapy include chimeric antigen receptor T cell (CAR-T), CAR-NK, and PD1/PDL1 checkpoint-blocking, which already are applied in the clinic and have verified unique advantages comparing to chemotherapy. The gene discussed is CD274; the disease is neoplasm.